Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
December 18, 2013
December 05, 2013
UCSF has been awarded a major federal grant to “transform and revolutionize” the treatment of prostate cancer, the second most common form of cancer among American men.
October 16, 2013
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
July 29, 2013
A group of scientists convened by the National Cancer Institute and chaired by a UCSF breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”
June 04, 2013
The turnout for this year's free skin cancer screening hosted by the UCSF Department of Dermatology made it one of the most successful. The blazing Saturday sun may have been an appropriate reminder about the importance for getting checked.
May 28, 2013
WHAT: The UC San Francisco Department of Dermatology is offering free skin cancer screenings. No appointment is necessary and no insurance is required. WHEN: Saturday, June 1, 8 a.m. to 4 p.m. The screenings will take approximately 30 minutes. WHERE: Castro Mission Health Center 3850 17th Street at Noe Street San Francisco, CA 94114
April 29, 2013
Surgery is often recommended for skin cancers, but older, sicker patients can endure complications as a result and may not live long enough to benefit from the treatment.
January 23, 2013
Ten years after the UCSF Mission Bay campus was established, UCSF Medical Center at Mission Bay – the key patient-care component of the campus – is only two years away from opening.
January 07, 2013
The National Cancer Institute has awarded the UCSF Helen Diller Family Comprehensive Cancer Center a $36 million support grant that will fund infrastructure for clinical trials, cutting-edge research and programmatic support over five years.
January 04, 2013
A team of UCSF researchers have conducted the most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness.